MedTrace Logo

Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease

NCT01711073 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-01-24

No results posted yet for this study

Summary

A phase I trial to study the safety of mobilization of stem cells with G-CSF and Mozobil in patients with chronic liver disease.

Conditions

  • End Stage Liver DIsease

Interventions

DRUG

Mobilization with G-CSF and Mozobil

Treatment with drugs for mobilization of MSCs

Sponsors & Collaborators

  • University of Medicine and Dentistry of New Jersey

    collaborator OTHER

  • Numoda

    collaborator INDUSTRY

  • Proteonomix, Inc.

    lead INDUSTRY

Principal Investigators

  • Baburao Koneru, MD · University of Medicine and Dentistry of New Jersey

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01711073 on ClinicalTrials.gov